Strategic Acquisition Promyc is now part of Naplasol, signaling a broader distribution network and stronger market reach through the VEOS Group. This presents cross-sell opportunities to VEOS-listed customers and leverage Naplasol’s production capabilities for larger orders and quickened go-to-market cycles.

Scale and Capacity Naplasol’s multi-million euro investment in a modern production plant and the stated capacity to deliver thousands of tons annually creates opportunities for large-scale supply contracts, co-development projects, and consistent SKU availability for end users seeking reliable mycoprotein ingredients.

Diverse Applications Promyc’s versatility across meat substitutes, dairy alternatives, dips, fish substitutes, and hybrid products opens doors to multiple category expansions for food manufacturers, pet food producers, and feed suppliers looking to diversify protein portfolios with a sustainable ingredient.

Sustainability Pitch A 100% natural, fungus-based protein with a neutral taste profile supports brands pursuing sustainability claims. Position Promyc as a high-protein, low-footprint ingredient ideal for clean-label, plant-forward product lines and regulatory-friendly formulations.

Market Momentum Recent acquisition news and ongoing investment indicate growing industry momentum for mycoprotein solutions. Use this as a conversation starter to engage potential customers about scalable supply, long-term partnerships, and being early adopters in a fast-evolving protein market.